INMED PHARMACEUTICALS (Germany) Analysis

MWG0 Stock   4.14  0.75  15.34%   
INMED PHARMACEUTICALS INC is overvalued with Real Value of 3.71 and Hype Value of 4.14. The main objective of INMED PHARMACEUTICALS stock analysis is to determine its intrinsic value, which is an estimate of what INMED PHARMACEUTICALS INC is worth, separate from its market price. There are two main types of INMED PHARMACEUTICALS's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect INMED PHARMACEUTICALS's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of INMED PHARMACEUTICALS's stock to identify patterns and trends that may indicate its future price movements.
The INMED PHARMACEUTICALS stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and INMED PHARMACEUTICALS's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in INMED PHARMACEUTICALS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in INMED Stock please use our How to Invest in INMED PHARMACEUTICALS guide.

INMED Stock Analysis Notes

The company had not issued any dividends in recent years. INMED PHARMACEUTICALS INC had 20:1 split on the 24th of September 2024.

INMED PHARMACEUTICALS INC Investment Alerts

INMED PHARMACEUTICALS is way too risky over 90 days horizon
INMED PHARMACEUTICALS appears to be risky and price may revert if volatility continues

Technical Drivers

As of the 24th of December, INMED PHARMACEUTICALS retains the risk adjusted performance of 0.0309, and Market Risk Adjusted Performance of (0.12). Our technical analysis interface lets you check practical technical drivers of INMED PHARMACEUTICALS INC, as well as the relationship between them. Please check out INMED PHARMACEUTICALS INC jensen alpha, maximum drawdown, and the relationship between the information ratio and treynor ratio to decide if INMED PHARMACEUTICALS is priced correctly, providing market reflects its last-minute price of 4.14 per share.

INMED PHARMACEUTICALS INC Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. INMED PHARMACEUTICALS middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for INMED PHARMACEUTICALS INC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

INMED PHARMACEUTICALS Outstanding Bonds

INMED PHARMACEUTICALS issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. INMED PHARMACEUTICALS INC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most INMED bonds can be classified according to their maturity, which is the date when INMED PHARMACEUTICALS INC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

INMED PHARMACEUTICALS Predictive Daily Indicators

INMED PHARMACEUTICALS intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of INMED PHARMACEUTICALS stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

INMED PHARMACEUTICALS Forecast Models

INMED PHARMACEUTICALS's time-series forecasting models are one of many INMED PHARMACEUTICALS's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary INMED PHARMACEUTICALS's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding INMED PHARMACEUTICALS to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Money Flow Index Now

   

Money Flow Index

Determine momentum by analyzing Money Flow Index and other technical indicators
All  Next Launch Module

Complementary Tools for INMED Stock analysis

When running INMED PHARMACEUTICALS's price analysis, check to measure INMED PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INMED PHARMACEUTICALS is operating at the current time. Most of INMED PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of INMED PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INMED PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of INMED PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets